← Browse by Condition
Medical Condition

recurrent pancreatic carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT04550494 Phase 2
Recruiting

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Enrollment
36 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →